甲型肝炎

American Academy of Pediatrics Committee on Infectious Diseases. Hepatitis A vaccine recommendations. Pediatrics. 2007;120:189-199.

• 全文
• 摘要

Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med. 2007;357:1685-1694.

• 全文
• 摘要

1.  American Academy of Pediatrics. Hepatitis A. In: Red Book: 2003 report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:309-318.

2.  Brundage SC, Fitzpatrick AN. Hepatitis A. Am Fam Physician. 2006;73:2162-2168.

• 全文
• 摘要

3.  Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med. 2004;350:476-481.

• 摘要

4.  Shenoy R, Nair S, Kamath N. Thrombocytopenia in hepatitis A: an atypical presentation. J Trop Pediatr. 2004;50:241-244.

• 摘要

5.  Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine. 1992;10(suppl 1):S18-S20.

• 摘要

6.  World Health Organization. Hepatitis A. 2000. http://www.who.int/ (last accessed 27 March 2017).

• 全文

7.  Hodges M, Sanders E, Aitken C. Seroprevalence of hepatitis markers; HAV, HBV, HCV and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med. 1998;17:36-37.

• 摘要

8.  Sawayama Y, Hayashi J, Ariyama I, et al. A ten year serological survey of hepatitis A, B, and C viruses infections in Nepal. J Epidemiol. 1999;9:350-354.

• 摘要

9.  Hau CH, Hien TT, Tien NT, et al. Prevalence of enteric hepatitis A and E viruses in the Mekong River delta region of Vietnam. Am J Trop Med Hyg. 1999;60:277-280.

• 摘要

10.  Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis. 1995;171:447-450.

• 摘要

11.  Beran J, Douda P, Rychly R. Seroprevalence of viral hepatitis in the Czech Republic. Eur J Epidemiol. 1999;15:805-808.

• 摘要

12.  Beutels M, Van Damme P, Aelvoet W, et al. Prevalence of hepatitis A, B and C in the Flemish population. Eur J Epidemiol. 1997;13:275-280.

• 摘要

13.  Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48:1-37.

• 全文
• 摘要

14.  Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics. 2002;109:839-845.

• 摘要

15.  Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005;294:194-201.

• 摘要

16.  Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis: United States, 2007. MMWR Surveill Summ. 2009;58:1-27.

• 全文
• 摘要

17.  Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am. 2000;14:605-615.

• 摘要

18.  Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev. 2001;14:38-58.

• 全文
• 摘要

19.  Atkinson W. Hepatitis A. In: Epidemiology and prevention of vaccine-preventable diseases. 8th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2005:177-189.

20.  Vallbracht A, Fleischer B, Busch FW. Hepatitis A: hepatotropism and influence on myelopoiesis. Intervirology. 1993;35:133-139.

• 摘要

21.  Fleischer B, Fleischer S, Maier K, et al. Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology. 1990;69:14-19.

• 摘要

22.  Baba M, Hasegawa H, Nakayabu M, et al. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. J Clin Lab Immunol. 1993;40:47-60.

• 摘要

23.  Rezende G, Roque-Afonso AM, Samuel D, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology. 2003;38:613-618.

• 摘要

24.  Centers for Disease Control and Prevention. Hepatitis surveillance: report number 60. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC; 2005.

25.  Mbithi JN, Springthorpe VS, Boulet JR, et al. Survival of hepatitis A virus on human hands and its transfer on contact with animate and inanimate surfaces. J Clin Microbiol. 1992;30:757-763.

• 摘要

26.  Irving GJ, Holden J, Yang R, et al. Hepatitis A immunisation in persons not previously exposed to hepatitis A. Cochrane Database Syst Rev. 2012;(7):CD009051.

• 全文
• 摘要

27.  Liu JP, Nikolova D, Fei Y. Immunoglobulins for preventing hepatitis A. Cochrane Database Syst Rev. 2009;(2):CD004181

• 全文
• 摘要

28.  American Academy of Pediatrics Committee on Infectious Diseases. Hepatitis A vaccine recommendations. Pediatrics. 2007;120:189-199.

• 全文
• 摘要

29.  World Health Organization. Hepatitis A vaccines: WHO position paper. Wkly Epidemiol Rec. 2000;75:38-44.

• 全文
• 摘要

30.  Public Health England. Hepatitis A: the green book, chapter 17. December 2013. https://www.gov.uk/ (last accessed 27 March 2017).

• 全文

31.  Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55:1-23.

• 全文
• 摘要

32.  Kim DK, Riley LE, Harriman KH, et al. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:136-138.

• 全文
• 摘要

33.  Robinson CL, Romero JR, Kempe A, et al. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:134-135.

• 全文
• 摘要

34.  Taylor RM, Davern T, Munoz S, et al. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology. 2006;44:1589-1597.

• 摘要

35.  Fujiwara K, Kojima H, Yasui S, et al. Hepatitis A viral load in relation to severity of the infection. J Med Virol. 2011;83:201-207.

• 摘要

36.  Ajmera V, Xia G, Vaughan G, et al; the Acute Liver Failure Study Group. What factors determine the severity of hepatitis A-related acute liver failure? J Viral Hepat. 2010;8:e167-74.

• 摘要

37.  Shin SJ, Kim JH. The characteristics of acute kidney injury complicated in acute hepatitis A. Scand J Infect Dis. 2009;41:869-872.

• 摘要

38.  Centers for Disease Control and Prevention. Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis: United States, 2002-2004. MMWR Morb Mortal Wkly Rep. 2005;54:453-456.

• 全文
• 摘要

39.  Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis. 1995;171(suppl 1):S15-S18.

• 摘要

40.  Vento S, Garofano T, Di Perri G, et al. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet. 1991;337:1183-1187.

• 摘要

41.  Rahaman SM, Chira P, Koff RS. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am J Gastroenterol. 1994;89:106-108.

• 摘要

42.  Crabb DW, Lumeng L. Alcoholic liver disease. In: Haubrich WS, Schaffner F, Berk JE, eds. Gastroenterology. 5th ed. Philadelphia, PA: WB Saunders; 1995:2215-2245.

43.  Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007;56:1080-1084.

• 全文
• 摘要

44.  Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med. 2007;357:1685-1694.

• 全文
• 摘要

45.  Chen W, Liu J, Gluud C. Bile acids for viral hepatitis. Cochrane Database Syst Rev. 2007;(4):CD003181.

• 全文
• 摘要

46.  Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine. 1992;10 (suppl 1):S15-S17.

• 摘要

47.  American Academy of Pediatrics. Hepatitis A. In: Pickering LK, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:326.